Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Medicine Année : 2018

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

(1) , (1) , (2) , (3) , (4) , (5) , (2) , (3) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (6) , (2) , (14) , (15) , (16, 6)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Emmanuelle Bompas
  • Fonction : Auteur correspondant
  • PersonId : 1041487

Connectez-vous pour contacter l'auteur
Loïc Campion
Antoine Italiano
Axel Le Cesne
  • Fonction : Auteur
Olivier Mir
  • Fonction : Auteur
  • PersonId : 892590
Isabelle Ray-Coquard

Résumé

Five-year overall survival (OS) of localized RMS exceeds 70% in children (<18) but is very poor in adult patients. We analyzed the outcome and prognostic factors (PF) of a national series of adult patients with RMS in a large study. The study population consisted of two different cohorts: a retrospective cohort (157 adult patients treated in 13 reference centers between 05/1981 and 02/2010) and the prospective cohort (292 patients with RMS diagnosed and treated between 01/2010 and 12/2014 in France) included in the NetSarc database. A descriptive analysis of patients' characteristics and prognostic factors was conducted on both series which were compared. In the retrospective series, histological subtypes were embryonal (E-RMS) for 21% of patients, alveolar (A-RMS) for 35% of patients, and "adult-type" P-RMS (pleomorphic, spindle cell RMS, not otherwise specified) (P) for 44% patients. This distribution significantly differed in the prospective cohort: A-RMS: 18%; E-RMS: 17%; and P-RMS 65%. With a median follow-up of 8.5 years, 5-year OS for localized RMS and advanced RMS (with nodes and/or metastases) was 43% and 5%, respectively, (P < 0.0001), and median OS was 51, 33, and 16 months for E-RMS, A-RMS, and P-RMS, respectively, in the retrospective cohort. The median OS was less than 40 months for the prospective nationwide cohort for the entire population. In a multivariate analysis of the retrospective study, independent prognostic factors for OS were A-RMS, R0 resection, and adjuvant radiotherapy (RT). For localized RMS, age and use of pediatric chemotherapy (CT) regimen are independent prognostic factors. Adult patients with RMS have a poorer overall survival than pediatric patients, and survival varies considerably across histological subtypes.
Fichier principal
Vignette du fichier
Outcome of 449 adult patients.pdf (297.5 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01978221 , version 1 (28-05-2020)

Licence

Paternité - CC BY 4.0

Identifiants

Citer

Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
204 Consultations
66 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More